The pandemic crisis may be over, but SARS-CoV-2 remains a major problem for the immunocompromised that do not make good antibody responses. European RCT confirms efficacy of COVID-19 convalescent plasma (CCP) in this population. CCP is FDA licensed in US

As physicians confront the widening measles outbreak it is important to keep in mind that we have a highly effective means of protecting those exposed - hyperimmune IgG. It showed 100% efficacy in the 2013 NYC outbreak.

As we enter another week of crisis in the biomedical sciences, I thought I would make a list of the advances in field of infectious diseases THAT I HAVE WITNESSED since I became board certified in 1990. I am sure I missed a few advances, and this is only in the field of ID.

Warmer climates could supercharge fungal diseases transmitted by insects. pubmed.ncbi.nlm.nih.gov/39907444/

Not a great picture since the window was cloudy from de-icing fluid. I am always impressed by the beauty of a sunset from a plane. Scenes like this take me back to my PhD qualifying exam where the first two questions were: why is the sky blue and the sunset red. I passed.

Monoclonal antibodies (mAb) for prevention of COVID-19 progression can affect subsequent infection/vaccination. Phenomenon was not seen with convalescent plasma and may reflect large IgG dose associated with mAb therapy.
pubmed.ncbi.nlm.nih.gov/39504352/